Although the hallmark of NF2 disease is glial cell tumours, there is increasing evidence that the ubiquitously expressed Merlin protein functions as a tumour suppressor in multiple cell types, including, for example, breast carcinoma and melanoma [6, 8]. This evidence concerns the gene NF2 and malignant glioma.